NCT05954338View on ClinicalTrials.gov

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 With DWC202307 in Healthy Adult Volunteers

PHASE1UnknownINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

DWC202307

DWC202307

DRUG

DWJ1543

DWJ1543

DRUG

DWC202216

DWC202216

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY